The maternal autoimmune environment affects the social behavior of offspring

Journal of Neuroimmunology

Volumn 258, Issue 1-2, 2013, Pages 51-60

  Zhang, Yubin ^a,b,c   Gao, Donghong ^a   Kluetzman, Kerri ^a   Mendoza, Alvaro ^a   Bolivar, Valerie J ^a,b   Reilly, Andrew ^a   Jolly, Jane K ^a   Lawrence, David A ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Autism; Autoimmune; B cells and T cells; Cytokines; Neuroinflammation; Social behavior

Indexed keywords

ALPHAVBETA6 INTEGRIN; AUTOANTIBODY; BRAIN ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 4; MATERNAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTISOCIAL PERSONALITY DISORDER; ARTICLE; AUTISM; AUTOIMMUNITY; BRAIN DEVELOPMENT; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FETUS DEVELOPMENT; FETUS OUTCOME; IMMUNOGLOBULIN PRODUCTION; IMMUNOPHENOTYPING; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; AUTISTIC DISORDER; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SOCIAL BEHAVIOR; SURFACE PLASMON RESONANCE;

EID: 84876713540     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.02.019     Document Type: Article

References (69)

1. Alexander A.L., Lee J.E., Lazar M., Boudos R., DuBray M.B., Oakes T.R., Miller J.N., Lu J., Jeong E.K., McMahon W.M., Bigler E.D., Lainhart J.E. Diffusion tensor imaging of the corpus callosum in autism. NeuroImage 2007, 34:61-73.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) 2000.
3. Ashwood P., Wills S., Van de Water J. The immune response in autism: a new frontier for autism research. J. Leukoc. Biol. 2006, 80:1-15.
4. Ashwood P., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R.L., Croen L.A., Ozonoff S., Pessah I.N., Van de Water J. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J. Neuroimmunol. 2008, 204:149-153.
5. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
6. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Altered T cell responses in children with autism. Brain Behav. Immun. 2011, 25:840-849.
7. Atladottir H.O., Thorsen P., Schendel D.E., Ostergaard L., Lemcke S., Parner E.T. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. Arch. Pediatr. Adolesc. Med. 2010, 164:470-477.
8. Barnea-Goraly N., Kwon H., Menon V., Eliez S., Lotspeich L., Reiss A.L. White matter structure in autism: preliminary evidence from diffusion tensor imaging. Biol. Psychiatry 2004, 55:323-326.
9. Bolivar V.J., Walters S.R., Phoenix J.L. Assessing autism-like behavior in mice: variations in social interactions among inbred strains. Behav. Brain Res. 2007, 176:21-26.
10. Bozzacco L., Yu H., Zebroski H.A., Dengjel J., Deng H., Mojsov S., Steinman R.M. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J. Proteome Res. 2011, 10:5016-5030.
11. Braunschweig D., Van de Water J. Maternal autoantibodies in autism. Arch. Neurol. 2012, 69:693-699.
12. Braunschweig D., Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 2008, 29:226-231.
13. Cabanlit M., Wills S., Goines P., Ashwood P., Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann. N. Y. Acad. Sci. 2007, 1107:92-103.
14. Centers for Disease Control, Prevention Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill. Summ. 2012, 61:1-19.
15. Chauhan A., Gu F., Essa M.M., Wegiel J., Kaur K., Brown W.T., Chauhan V. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J. Neurochem. 2011, 117:209-220.
16. Croonenberghs J., Wauters A., Devreese K., Verkerk R., Scharpe S., Bosmans E., Egyed B., Deboutte D., Maes M. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol. Med. 2002, 32:1457-1463.
17. Denenberg V.H., Sherman G.F., Schrott L.M., Rosen G.D., Galaburda A.M. Spatial learning, discrimination learning, paw preference and neocortical ectopias in two autoimmune strains of mice. Brain Res. 1991, 562:98-104.
18. Eagleson K.L., Campbell D.B., Thompson B.L., Bergman M.Y., Levitt P. The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res. 2011, 4:68-83.
19. Enstrom A., Krakowiak P., Onore C., Pessah I.N., Hertz-Picciotto I., Hansen R.L., Van de Water J.A., Ashwood P. Increased IgG4 levels in children with autism disorder. Brain Behav. Immun. 2009, 23:389-395.
20. Enstrom A.M., Lit L., Onore C.E., Gregg J.P., Hansen R.L., Pessah I.N., Hertz-Picciotto I., Van de Water J.A., Sharp F.R., Ashwood P. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 2009, 23:124-133.
21. Fukui Y., Ishimoto T., Utsuyama M., Gyotoku T., Koga T., Nakao K., Hirokawa K., Katsuki M., Sasazuki T. Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity 1997, 6:401-410.
22. Ganz M.L. The lifetime distribution of the incremental societal costs of autism. Arch. Pediatr. Adolesc. Med. 2007, 161:343-349.
23. Giarelli E., Wiggins L.D., Rice C.E., Levy S.E., Kirby R.S., Pinto-Martin J., Mandell D. Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disabil. Health J. 2010, 3:107-116.
24. Giulivi C., Zhang Y.F., Omanska-Klusek A., Ross-Inta C., Wong S., Hertz-Picciotto I., Tassone F., Pessah I.N. Mitochondrial dysfunction in autism. JAMA 2010, 304:2389-2396.
25. Goines P., Van de Water J. The immune system's role in the biology of autism. Curr. Opin. Neurol. 2010, 23:111-117.
26. Goines P., Haapanen L., Boyce R., Duncanson P., Braunschweig D., Delwiche L., Hansen R., Hertz-Picciotto I., Ashwood P., Van de Water J. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav. Immun. 2011, 25:514-523.
27. Gupta S., Aggarwal S., Rashanravan B., Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 1998, 85:106-109.
28. Gurney J.G., Fritz M.S., Ness K.K., Sievers P., Newschaffer C.J., Shapiro E.G. Analysis of prevalence trends of autism spectrum disorder in Minnesota. Arch. Pediatr. Adolesc. Med. 2003, 157:622-627.
29. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., Lotspeich L., Croen L.A., Ozonoff S., Lajonchere C., Grether J.K., Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 2011, 68:1095-1102.
30. Heo Y., Zhang Y., Gao D., Miller V.M., Lawrence D.A. Aberrant immune responses in a mouse with behavioral disorders. PLoS One 2011, 6:e20912.
31. Heuer L., Ashwood P., Schauer J., Goines P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 2008, 1:275-283.
32. Hsiao E.Y., McBride S.W., Chow J., Mazmanian S.K., Patterson P.H. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12776-12781.
33. Hultman P., Johansson U., Dagnaes-Hansen F. Murine mercury-induced autoimmunity: the role of T-helper cells. J. Autoimmun. 1995, 8:809-823.
34. Jick H., Kaye J.A. Epidemiology and possible causes of autism. Pharmacotherapy 2003, 23:1524-1530.
35. Jolous-Jamshidi B., Cromwell H.C., McFarland A.M., Meserve L.A. Perinatal exposure to polychlorinated biphenyls alters social behaviors in rats. Toxicol. Lett. 2010, 199:136-143.
36. Kalkbrenner A.E., Daniels J.L., Chen J.C., Poole C., Emch M., Morrissey J. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 2010, 21:631-641.
37. Kroenke M.A., Segal B.M. IL-23 modulated myelin-specific T cells induce EAE via an IFNgamma driven, IL-17 independent pathway. Brain Behav. Immun. 2011, 25:932-937.
38. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
39. Malkova N.V., Yu C.Z., Hsiao E.Y., Moore M.J., Patterson P.H. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 2012, 26:607-616.
40. Marks B.R., Nowyhed H.N., Choi J.Y., Poholek A.C., Odegard J.M., Flavell R.A., Craft J. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat. Immunol. 2009, 10:1125-1132.
41. Martin L.A., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 2008, 22:806-816.
42. Marusov G., Sweatt A., Pietrosimone K., Benson D., Geary S.J., Silbart L.K., Challa S., Lagoy J., Lawrence D.A., Lynes M.A. A microarray biosensor for multiplexed detection of microbes using grating-coupled surface plasmon resonance imaging. Environ. Sci. Technol. 2012, 46:348-359.
43. McFarlane H.G., Kusek G.K., Yang M., Phoenix J.L., Bolivar V.J., Crawley J.N. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav. 2008, 7:152-163.
44. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 2006, 172:198-205.
45. Molony R.D., Rice J.M., Yuk J.S., Shetty V., Dey D., Lawrence D.A., Lynes M.A. Mining the salivary proteome with grating-coupled surface plasmon resonance imaging and surface plasmon coupled emission microarrays. Curr. Protoc. Toxicol. 2012, 16:1-19. [Chapter 18, Unit 18].
46. Mostafa G.A., Al Shehab A., Fouad N.R. Frequency of CD4+CD25high regulatory T cells in the peripheral blood of Egyptian children with autism. J. Child Neurol. 2010, 25:328-335.
47. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., Barbaro J.R., Wilson L.M., Threadgill D.W., Lauder J.M., Magnuson T.R., Crawley J.N. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav. Brain Res. 2007, 176:4-20.
48. Mulvihill Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill. Summ. 2009, 58:1-20.
49. Nagy A., Gertsenstein M., Vintersten K., Behringer R. Manipulating the Mouse Embryo 2003, Cold Spring Harbor Laboratory Press, NY. 3rd ed.
50. Okada K., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., Sekine Y., Suda S., Suzuki K., Sugihara G., Matsuzaki H., Sugiyama T., Kawai M., Minabe Y., Takei N., Mori N. Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:187-190.
51. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
52. Petkov P.M., Ding Y., Cassell M.A., Zhang W., Wagner G., Sargent E.E., Asquith S., Crew V., Johnson K.A., Robinson P., Scott V.E., Wiles M.V. An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res. 2004, 14:1806-1811.
53. Reynolds J.M., Pappu B.P., Peng J., Martinez G.J., Zhang Y., Chung Y., Ma L., Yang X.O., Nurieva R.I., Tian Q., Dong C. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 2010, 32:692-702.
54. Roberts E.M., English P.B., Grether J.K., Windham G.C., Somberg L., Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ. Health Perspect. 2007, 115:1482-1489.
55. Santori F.R., Kieper W.C., Brown S.M., Lu Y., Neubert T.A., Johnson K.L., Naylor S., Vukmanovic S., Hogquist K.A., Jameson S.C. Rare, structurally homologous self-peptides promote thymocyte positive selection. Immunity 2002, 17:131-142.
56. Singer H.S., Morris C.M., Gause C.D., Gillin P.K., Crawford S., Zimmerman A.W. Antibodies against fetal brain in sera of mothers with autistic children. J. Neuroimmunol. 2008, 194:165-172.
57. Singer H.S., Morris C., Gause C., Pollard M., Zimmerman A.W., Pletnikov M. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J. Neuroimmunol. 2009, 211:39-48.
58. Singh V.K. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 1996, 66:143-145.
59. Suzuki K., Matsuzaki H., Iwata K., Kameno Y., Shimmura C., Kawai S., Yoshihara Y., Wakuda T., Takebayashi K., Takagai S., Matsumoto K., Tsuchiya K.J., Iwata Y., Nakamura K., Tsujii M., Sugiyama T., Mori N. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6:e20470.
60. Sweeten T.L., Posey D.J., McDougle C.J. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry 2003, 160:1691-1693.
61. Takahama Y., Nitta T., Mat Ripen A., Nitta S., Murata S., Tanaka K. Role of thymic cortex-specific self-peptides in positive selection of T cells. Semin. Immunol. 2010, 22:287-293.
62. Tetreault N.A., Hakeem A.Y., Jiang S., Williams B.A., Allman E., Wold B.J., Allman J.M. Microglia in the cerebral cortex in autism. J. Autism Dev. Disord. 2012, 42:2569-2584.
63. Viret C., Leung-Theung-Long S., Serre L., Lamare C., Vignali D.A., Malissen B., Carrier A., Guerder S. Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice. J. Clin. Invest. 2011, 121:1810-1821.
64. Vojdani A., Mumper E., Granpeesheh D., Mielke L., Traver D., Bock K., Hirani K., Neubrander J., Woeller K.N., O'Hara N., Usman A., Schneider C., Hebroni F., Berookhim J., McCandless J. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J. Neuroimmunol. 2008, 205:148-154.
65. Wahlsten D., Metten P., Crabbe J.C. Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T/+ tf/tf has severely reduced hippocampal commissure and absent corpus callosum. Brain Res. 2003, 971:47-54.
66. Wen Z., Xu L., Xu W., Xiong S. Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus model was dependent on CD4+ T cells. Lupus 2012, 21:508-516.
67. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D.G., Van de Water J. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav. Immun. 2009, 23:64-74.
68. Yang P., Li B., Lv P., Zhang Y., Gao X.M. Interaction between antigen presenting cells and autoreactive T cells derived from BXSB mice with murine lupus. Cell Res. 2007, 17:556-564.
69. Zimmerman A.W., Connors S.L., Matteson K.J., Lee L.C., Singer H.S., Castaneda J.A., Pearce D.A. Maternal antibrain antibodies in autism. Brain Behav. Immun. 2007, 21:351-357.